“Myocardial Salvaging Effects and Mechanisms of Dipeptidyl Peptidase-IV Inhibitor Vildagliptin in Experimental Diabetes”. 2016. International Journal of Biomedical Research 7 (5): 276-82. https://doi.org/10.7439/ijbr.v7i5.3273.